References
- Ahvonen P. Human yersiniosis in Finland. Ann Clin Res 1972; 4: 39–48
- Arpi M, Jensen KT., Frederiksen W. Yesinia enterocolitica bacteremia: an analysis of thirty-six patients in Denmark and a review of the literature. Contrib Microbiol Immunol 1991; 12: 260–264
- Yamashiro KM., Goldman RH., Harris D, Uyeda CT. Pasteurella pseudotuberculosis. Acute sepsis with survival. Arch Intern Med 1971; 128: 605–608
- Macaulay JD., Wilson J AC, Abbott JD., Mair NS. Fatal case of Pasteurella pseudotuberculosis infection associates with hepatic cirrhosis. Br Med J 1967; 2: 553–554
- Butler T. Yersinia species. Principle and practice of infectious diseases, 4th ed., GL. Mandell, RG. Douglas, JE. Bennett. Churchill Livingstone, New York 1995; 2070–2078
- Parillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471–1477
- Parker MM., Shelhamer JH., Bacharach SL., Green MV., Natanson Ch, Frederick TM., Damske BA., Parillo JE. Profound but reversible myocardiai depression in patients with septic shock. Ann Intern Med 1984; 100: 483–490
- Glauser MP., Heumann D, Baumgartner JD., Cohen J. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin Infect Dis 1994; 18: S205–S216
- Schulz R, Nava E, Moncada S. Induction and potential biological relevance of a Ca+ -independent nitric oxide synthase in the myocardium. Br J. Pharmacol 1992; 105: 575–580
- Finkel MS., Oddis CV., Jacob TD., Watkins SC., Hattler BG., Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–389
- Petros A, Bennett D, Vallance P. Effect of nitric oxide synthesis inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557–1558
- Casey LC., Balk RA., Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771–778
- Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169: 333–338
- Marchant A, Devière J, Byl B, De Groote D, Vincent J-L, Goldman M. Interleukin-10 production during septicaemia. Lancet 1994; 343: 707–708
- Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177: 1205–1208
- Gérard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177: 547–550
- Vincent J-L, Bakker J, Marecaux G, Schandene L, Kahn RJ., Dupont E. Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Chest 1992; 101: 810–815